Morphine use in cancer surgery

Banafsheh Afsharimani, Peter J Cabot, Marie-Odile Parat, Banafsheh Afsharimani, Peter J Cabot, Marie-Odile Parat

Abstract

Morphine is the core of perioperative pain management. However, when it comes to cancer surgery the possibility that this drug might affect tumor recurrence and metastasis has raised concerns. The results of two recent retrospective clinical trials indicated that regional anesthesia/analgesia might be beneficial in prostate and breast cancer surgery. It was proposed that morphine could be responsible for the higher recurrence and mortality rate observed in the general anesthesia/opioid analgesia groups. Nevertheless, the results of several other retrospective studies and one randomized prospective trial failed to confirm any advantage for regional anesthesia/analgesia over general anesthesia and opioid analgesia. Moreover laboratory data on the effect of morphine on cancer are contradictory, ranging from tumor-promoting to anti-tumor effects. Considering that surgical stress and pain promote the recurrence and spread of cancer, choosing a proper analgesic strategy is of high significance. Although the question of whether morphine causes any harm to cancer patients remains unanswered, alternative analgesic regimens could be used concomitant to or instead of morphine to limit its potential adverse effects.

Keywords: analgesia; anesthesia; cancer; morphine; regional; surgery.

References

    1. Anonymous (1991). Postoperative pain relief and non-opioid analgesics. Lancet 337, 524–526
    1. Afsharimani B., Cabot P., Parat M. O. (2011). Morphine and tumor growth and metastasis. Cancer Metastasis Rev. 30, 225–238
    1. Akural E. I., Salomaki T. E., Bloigu A. H., Ryhanen P., Tekay A. H., Alahuhta S. M., Surcel H. M. (2004). The effects of pre-emptive epidural sufentanil on human immune function. Acta Anaesthesiol. Scand. 48, 750–755
    1. Balasubramanian S., Ramakrishnan S., Charboneau R., Wang J., Barke R. A., Roy S. (2001). Morphine sulfate inhibits hypoxia-induced vascular endothelial growth factor expression in endothelial cells and cardiac myocytes. J. Mol. Cell. Cardiol. 33, 2179–2187
    1. Bar-Yosef S., Melamed R., Page G. G., Shakhar G., Shakhar K., Ben-Eliyahu S. (2001). Attenuation of the tumor-promoting effect of surgery by spinal blockade in rats. Anesthesiology 94, 1066–1073
    1. Beilin B., Shavit Y., Hart J., Mordashov B., Cohn S., Notti I., Bessler H. (1996). Effects of anesthesia based on large versus small doses of fentanyl on natural killer cell cytotoxicity in the perioperative period. Anesth. Analg. 82, 492–49710.1097/00000539-199604000-00062
    1. Benish M., Bartal I., Goldfarb Y., Levi B., Avraham R., Raz A., Ben-Eliyahu S. (2008). Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis. Ann. Surg. Oncol. 15, 2042–2052
    1. Biki B., Mascha E., Moriarty D. C., Fitzpatrick J. M., Sessler D. I., Buggy D. J. (2008). Anesthetic technique for radical prostatectomy surgery affects cancer recurrence: a retrospective analysis. Anesthesiology 109, 180–187
    1. Bilfinger T. V., Fimiani C., Stefano G. B. (1998). Morphine’s immunoregulatory actions are not shared by fentanyl. Int. J. Cardiol. 64(Suppl. 1), S61–S66
    1. Blebea J., Mazo J. E., Kihara T. K., Vu J. H., Mclaughlin P. J., Atnip R. G., Zagon I. S. (2000). Opioid growth factor modulates angiogenesis. J. Vasc. Surg. 32, 364–37310.1067/mva.2000.107763b
    1. Bruzzone A., Pinero C. P., Castillo L. F., Sarappa M. G., Rojas P., Lanari C., Luthy I. A. (2008). Alpha2-adrenoceptor action on cell proliferation and mammary tumour growth in mice. Br. J. Pharmacol. 155, 494–504
    1. Buvanendran A., Kroin J. S. (2009). Multimodal analgesia for controlling acute postoperative pain. Curr. Opin. Anaesthesiol. 22, 588–593
    1. Cashman J. N., Jones R. M., Foster J. M., Adams A. P. (1985). Comparison of infusions of morphine and lysine acetyl salicylate for the relief of pain after surgery. Br. J. Anaesth. 57, 255–25810.1093/bja/57.5.488
    1. Chia Y. Y., Chan M. H., Ko N. H., Liu K. (2004). Role of beta-blockade in anaesthesia and postoperative pain management after hysterectomy. Br. J. Anaesth. 93, 799–805
    1. Christopherson R., James K. E., Tableman M., Marshall P., Johnson F. E. (2008). Long-term survival after colon cancer surgery: a variation associated with choice of anesthesia. Anesth. Analg. 107, 325–332
    1. Colacchio T. A., Yeager M. P., Hildebrandt L. W. (1994). Perioperative immunomodulation in cancer surgery. Am. J. Surg. 167, 174–17910.1016/0002-9610(94)90070-1
    1. Collard V., Mistraletti G., Taqi A., Asenjo J. F., Feldman L. S., Fried G. M., Carli F. (2007). Intraoperative esmolol infusion in the absence of opioids spares postoperative fentanyl in patients undergoing ambulatory laparoscopic cholecystectomy. Anesth. Analg. 105, 1255–1262
    1. Dahl J. B., Mathiesen O., Kehlet H. (2010). An expert opinion on postoperative pain management, with special reference to new developments. Expert Opin. Pharmacother. 11, 2459–247010.1517/14656566.2010.499124
    1. Deegan C. A., Murray D., Doran P., Ecimovic P., Moriarty D. C., Buggy D. J. (2009). Effect of anaesthetic technique on oestrogen receptor-negative breast cancer cell function in vitro. Br. J. Anaesth. 103, 685–690
    1. Deegan C. A., Murray D., Doran P., Moriarty D. C., Sessler D. I., Mascha E., Kavanagh B. P., Buggy D. J. (2010). Anesthetic technique and the cytokine and matrix metalloproteinase response to primary breast cancer surgery. Reg. Anesth. Pain Med. 35, 490–495
    1. Dirks J., Fredensborg B. B., Christensen D., Fomsgaard J. S., Flyger H., Dahl J. B. (2002). A randomized study of the effects of single-dose gabapentin versus placebo on postoperative pain and morphine consumption after mastectomy. Anesthesiology 97, 560–564
    1. Eckhardt K., Ammon S., Hofmann U., Riebe A., Gugeler N., Mikus G. (2000). Gabapentin enhances the analgesic effect of morphine in healthy volunteers. Anesth. Analg. 91, 185–19110.1213/00000539-200007000-00035
    1. Exadaktylos A. K., Buggy D. J., Moriarty D. C., Mascha E., Sessler D. I. (2006). Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology 105, 660–66410.1097/00000542-200610000-00008
    1. Faramarzi N., Abbasi A., Tavangar S. M., Mazouchi M., Dehpour A. R. (2009). Opioid receptor antagonist promotes angiogenesis in bile duct ligated rats. J. Gastroenterol. Hepatol. 24, 1226–122910.1111/j.1440-1746.2009.05794.x
    1. Farooqui M., Geng Z. H., Stephenson E. J., Zaveri N., Yee D., Gupta K. (2006). Naloxone acts as an antagonist of estrogen receptor activity in MCF-7 cells. Mol. Cancer Ther. 5, 611–620
    1. Farooqui M., Li Y., Rogers T., Poonawala T., Griffin R. J., Song C. W., Gupta K. (2007). COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia. Br. J. Cancer 97, 1523–153110.1038/sj.bjc.6604057
    1. Fassoulaki A., Patris K., Sarantopoulos C., Hogan Q. (2002). The analgesic effect of gabapentin and mexiletine after breast surgery for cancer. Anesth. Analg. 95, 985–99110.1097/00000539-200210000-00036
    1. Forget P., De Kock M. (2009). Could anaesthesia, analgesia and sympathetic modulation affect neoplasic recurrence after surgery? A systematic review centred over the modulation of natural killer cells activity. Ann. Fr. Anesth. Reanim. 28, 751–768
    1. Forget P., Vandenhende J., Berliere M., Machiels J.-P., Nussbaum B., Legrand C., De Kock M. (2010). Do intraoperative analgesics influence breast cancer recurrence after mastectomy? A retrospective analysis. Anesth. Analg. 110, 1630–163510.1213/ANE.0b013e3181d2ad07
    1. Franchi S., Panerai A. E., Sacerdote P. (2007). Buprenorphine ameliorates the effect of surgery on hypothalamus-pituitary-adrenal axis, natural killer cell activity and metastatic colonization in rats in comparison with morphine or fentanyl treatment. Brain Behav. Immun. 21, 767–774
    1. Gottschalk A., Ford J. G., Regelin C. C., You J., Mascha E. J., Sessler D. I., Durieux M. E., Nemergut E. C. (2010a). Association between epidural analgesia and cancer recurrence after colorectal cancer surgery. Anesthesiology 113, 27–3410.1097/ALN.0b013e3181de6d0d
    1. Gottschalk A., Sharma S., Ford J., Durieux M. E., Tiouririne M. (2010b). Review article: the role of the perioperative period in recurrence after cancer surgery. Anesth. Analg. 110, 1636–1643
    1. Gupta K., Kshirsagar S., Chang L., Schwartz R., Law P. Y., Yee D., Hebbel R. P. (2002). Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Res. 62, 4491–4498
    1. Hadi M. A., Kamaruljan H. S., Saedah A., Abdullah N. M. (2006). A comparative study of intravenous patient-controlled analgesia morphine and tramadol in patients undergoing major operation. Med. J. Malaysia 61, 570–576
    1. Harimaya Y., Koizumi K., Andoh T., Nojima H., Kuraishi Y., Saiki I. (2002). Potential ability of morphine to inhibit the adhesion, invasion and metastasis of metastatic colon 26-L5 carcinoma cells. Cancer Lett. 187, 121–127
    1. Hatzoglou A., Bakogeorgou E., Castanas E. (1996). The antiproliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptors. Eur. J. Pharmacol. 296, 199–20710.1016/0014-2999(95)00703-2
    1. Hopkins D., Shipton E. A., Potgieter D., Van Dermerwe C. A., Boon J., De Wet C., Murphy J. (1998). Comparison of tramadol and morphine via subcutaneous PCA following major orthopaedic surgery. Can. J. Anaesth. 45, 435–44210.1007/BF03012579
    1. Hsiao P.-N., Chang M.-C., Cheng W.-F., Chen C.-A., Lin H.-W., Hsieh C.-Y., Sun W.-Z. (2009). Morphine induces apoptosis of human endothelial cells through nitric oxide and reactive oxygen species pathways. Toxicology 256, 83–9110.1016/j.tox.2008.11.015
    1. Ishikawa M., Tanno K., Kamo A., Takayanagi Y., Sasaki K. (1993). Enhancement of tumor growth by morphine and its possible mechanism in mice. Biol. Pharm. Bull. 16, 762–766
    1. Ismail H., Ho K. M., Narayan K., Kondalsamy-Chennakesavan S. (2010). Effect of neuraxial anaesthesia on tumour progression in cervical cancer patients treated with brachytherapy: a retrospective cohort study. Br. J. Anaesth. 105, 145–149
    1. Johansen J. W., Schneider G., Windsor A. M., Sebel P. S. (1998). Esmolol potentiates reduction of minimum alveolar isoflurane concentration by alfentanil. Anesth. Analg. 87, 671–676
    1. Koodie L., Ramakrishnan S., Roy S. (2010). Morphine suppresses tumor angiogenesis through a HIF-1{alpha}/p38mapk pathway. Am. J. Pathol. 177, 984–997
    1. Lam C. F., Chang P. J., Huang Y. S., Sung Y. H., Huang C. C., Lin M. W., Liu Y. C., Tsai Y. C. (2008). Prolonged use of high-dose morphine impairs angiogenesis and mobilization of endothelial progenitor cells in mice. Anesth. Analg. 107, 686–69210.1213/ane.0b013e31817e6719
    1. Leppert W. (2009). Tramadol as an analgesic for mild to moderate cancer pain. Pharmacol. Rep. 61, 978–992
    1. Looney M., Doran P., Buggy D. J. (2010). Effect of anesthetic technique on serum vascular endothelial growth factor C and transforming growth factor beta in women undergoing anesthesia and surgery for breast cancer. Anesthesiology 113, 1118–1125
    1. Maneckjee R., Biswas R., Vonderhaar B. K. (1990). Binding of opioids to human MCF-7 breast cancer cells and their effects on growth. Cancer Res. 50, 2234–2238
    1. Maneckjee R., Minna J. D. (1994). Opioids induce while nicotine suppresses apoptosis in human lung cancer cells. Cell Growth Differ. 5, 1033–1040
    1. Martin J. L., Charboneau R., Barke R. A., Roy S. (2010a). Chronic morphine treatment inhibits LPS-induced angiogenesis: implications in wound healing. Cell. Immunol. 265, 139–145
    1. Martin J. L., Koodie L., Krishnan A. G., Charboneau R., Barke R. A., Roy S. (2010b). Chronic morphine administration delays wound healing by inhibiting immune cell recruitment to the wound site. Am. J. Pathol. 176, 786–799
    1. Mathew B., Lennon F. E., Siegler J., Mirzapoiazova T., Mambetsariev N., Sammani S., Gerhold L. M., Lariviere P. J., Chen C. T., Garcia J. G., Salgia R., Moss J., Singleton P. A. (2011). The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation. Anesth. Analg. 112, 558–56710.1213/ANE.0b013e31820568af
    1. Mathiesen O., Moiniche S., Dahl J. B. (2007). Gabapentin and postoperative pain: a qualitative and quantitative systematic review, with focus on procedure. BMC Anesthesiol. 7, 6.10.1186/1471-2253-7-6
    1. Méric J.-B., Rottey S., Olaussen K., Soria J.-C., Khayat D., Rixe O., Spano J.-P. (2006). Cyclooxygenase-2 as a target for anticancer drug development. Crit. Rev. Oncol. Hematol. 59, 51–64
    1. Murphy D. F. (1993). Nsaids and postoperative pain. BMJ 306, 1493–1494
    1. Myles P. S., Peyton P., Silbert B., Hunt J., Rigg J. R., Sessler D. I. (2011). Perioperative epidural analgesia for major abdominal surgery for cancer and recurrence-free survival: randomised trial. BMJ 342, d1491.
    1. O’Riain S. C., Buggy D. J., Kerin M. J., Watson R. W., Moriarty D. C. (2005). Inhibition of the stress response to breast cancer surgery by regional anesthesia and analgesia does not affect vascular endothelial growth factor and prostaglandin E2. Anesth. Analg. 100, 244–249
    1. Page G. G., Ben-Eliyahu S., Liebeskind J. C. (1994). The role of LGL/NK cells in surgery-induced promotion of metastasis and its attenuation by morphine. Brain Behav. Immun. 8, 241–250
    1. Page G. G., Ben-Eliyahu S., Yirmiya R., Liebeskind J. C. (1993). Morphine attenuates surgery-induced enhancement of metastatic colonization in rats. Pain 54, 21–28
    1. Page G. G., Blakely W. P., Ben-Eliyahu S. (2001). Evidence that postoperative pain is a mediator of the tumor-promoting effects of surgery in rats. Pain 90, 191–199
    1. Page G. G., Mcdonald J. S., Ben-Eliyahu S. (1998). Pre-operative versus postoperative administration of morphine: impact on the neuroendocrine, behavioural, and metastatic-enhancing effects of surgery. Br. J. Anaesth. 81, 216–223
    1. Paice J. (2003). “Management of the patient with pain,” in Surgical Oncology: An Algorithmic Approach, eds Saclarides T., Millikan K., Godellas C. (New York: Springer-Verlag; ), 712–720
    1. Palm D., Lang K., Niggemann B., Drell T. L. T., Masur K., Zaenker K. S., Entschladen F. (2006). The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by beta-blockers. Int. J. Cancer 118, 2744–274910.1002/ijc.21723
    1. Pasi A., Qu B. X., Steiner R., Senn H. J., Bar W., Messiha F. S. (1991). Angiogenesis: modulation with opioids. Gen. Pharmacol. 22, 1077–1079
    1. Pyati S., Gan T. J. (2007). Perioperative pain management. CNS Drugs 21, 185–21110.2165/00023210-200721030-00002
    1. Romundstad L., Stubhaug A. (2007). Glucocorticoids for acute and persistent postoperative neuropathic pain: what is the evidence? Anesthesiology 107, 371–37310.1097/01.anes.0000279487.27940.5c
    1. Sacerdote P., Bianchi M., Gaspani L., Manfredi B., Maucione A., Terno G., Ammatuna M., Panerai A. E. (2000). The effects of tramadol and morphine on immune responses and pain after surgery in cancer patients. Anesth. Analg. 90, 1411–1414
    1. Sacerdote P., Bianchi M., Gaspani L., Panerai A. E. (1999). Effects of tramadol and its enantiomers on concanavalin-A induced-proliferation and NK activity of mouse splenocytes: involvement of serotonin. Int. J. Immunopharmacol. 21, 727–73410.1016/S0192-0561(99)00048-X
    1. Sacerdote P., Gaspani L., Rossoni G., Panerai A. E., Bianchi M. (2001). Effect of the opioid remifentanil on cellular immune response in the rat. Int. Immunopharmacol. 1, 713–71910.1016/S1567-5769(01)00005-4
    1. Salerno A., Hermann R. (2006). Efficacy and safety of steroid use for postoperative pain relief. Update and review of the medical literature. J. Bone Joint Surg. Am. 88, 1361–137210.2106/JBJS.D.03018
    1. Sasamura T., Nakamura S., Iida Y., Fujii H., Murata J., Saiki I., Nojima H., Kuraishi Y. (2002). Morphine analgesia suppresses tumor growth and metastasis in a mouse model of cancer pain produced by orthotopic tumor inoculation. Eur. J. Pharmacol. 441, 185–191
    1. Schlagenhauff B., Ellwanger U., Breuninger H., Stroebel W., Rassner G., Garbe C. (2000). Prognostic impact of the type of anaesthesia used during the excision of primary cutaneous melanoma. Melanoma Res. 10, 165–169
    1. Shavit Y., Ben-Eliyahu S., Zeidel A., Beilin B. (2004). Effects of fentanyl on natural killer cell activity and on resistance to tumor metastasis in rats. Dose and timing study. Neuroimmunomodulation 11, 255–26010.1159/000078444
    1. Singleton P. A., Garcia J. G., Moss J. (2008). Synergistic effects of methylnaltrexone with 5-fluorouracil and bevacizumab on inhibition of vascular endothelial growth factor-induced angiogenesis. Mol. Cancer Ther. 7, 1669–1679
    1. Singleton P. A., Lingen M. W., Fekete M. J., Garcia J. G., Moss J. (2006). Methylnaltrexone inhibits opiate and VEGF-induced angiogenesis: role of receptor transactivation. Microvasc. Res. 72, 3–11
    1. Singleton P. A., Mambetsariev N., Lennon F. E., Mathew B., Siegler J. H., Moreno-Vinasco L., Salgia R., Moss J., Garcia J. G. (2010). Methylnaltrexone potentiates the anti-angiogenic effects of mtor inhibitors. J. Angiogenes. Res. 2, 5.
    1. Singleton P. A., Moreno-Vinasco L., Sammani S., Wanderling S. L., Moss J., Garcia J. G. (2007). Attenuation of vascular permeability by methylnaltrexone: role of mop-R and S1P3 transactivation. Am. J. Respir. Cell Mol. Biol. 37, 222–231
    1. Singleton P. A., Moss J. (2010). Effect of perioperative opioids on cancer recurrence: a hypothesis. Future Oncol. 6, 1237–1242
    1. Stamer U. M., Maier C., Grond S., Veh-Schmidt B., Klaschik E., Lehmann K. A. (1997). Tramadol in the management of post-operative pain: a double-blind, placebo- and active drug-controlled study. Eur. J. Anaesthesiol. 14, 646–654
    1. Sueoka E., Sueoka N., Kai Y., Okabe S., Suganuma M., Kanematsu K., Yamamoto T., Fujiki H. (1998). Anticancer activity of morphine and its synthetic derivative, KT-90, mediated through apoptosis and inhibition of NF-kappab activation. Biochem. Biophys. Res. Commun. 252, 566–57010.1006/bbrc.1998.9695
    1. Tegeder I., Grosch S., Schmidtko A., Haussler A., Schmidt H., Niederberger E., Scholich K., Geisslinger G. (2003). G protein-independent G1 cell cycle block and apoptosis with morphine in adenocarcinoma cells: involvement of p53 phosphorylation. Cancer Res. 63, 1846–1852
    1. Tiippana E. M., Hamunen K., Kontinen V. K., Kalso E. (2007). Do surgical patients benefit from perioperative gabapentin/pregabalin? A systematic review of efficacy and safety. Anesth. Analg. 104, 1545–1556
    1. Tsai Y. C., Won S. J. (2001). Effects of tramadol on T lymphocyte proliferation and natural killer cell activity in rats with sciatic constriction injury. Pain 92, 63–69
    1. Tsui B., Rashiq S., Schopflocher D., Murtha A., Broemling S., Pillay J., Finucane B. (2010). Epidural anesthesia and cancer recurrence rates after radical prostatectomy. Can. J. Anesth. 57, 107–112
    1. Ustun F., Durmus-Altun G., Altaner S., Tuncbilek N., Uzal C., Berkarda S. (2010). Evaluation of morphine effect on tumour angiogenesis in mouse breast tumour model, EATC. Med. Oncol. 1–9
    1. Vickers M. D., Paravicini D. (1995). Comparison of tramadol with morphine for post-operative pain following abdominal surgery. Eur. J. Anaesthesiol. 12, 265–271
    1. Wada H., Seki S., Takahashi T., Kawarabayashi N., Higuchi H., Habu Y., Sugahara S., Kazama T. (2007). Combined spinal and general anesthesia attenuates liver metastasis by preserving TH1/TH2 cytokine balance. Anesthesiology 106, 499–506
    1. White P. F., Wang B., Tang J., Wender R. H., Naruse R., Sloninsky A. (2003). The effect of intraoperative use of esmolol and nicardipine on recovery after ambulatory surgery. Anesth. Analg. 97, 1633–163810.1213/01.ANE.0000073350.96933.A1
    1. Yeager M. P., Colacchio T. A. (1991). Effect of morphine on growth of metastatic colon cancer in vivo. Arch Surg. 126, 454–456
    1. Yeager M. P., Procopio M. A., Deleo J. A., Arruda J. L., Hildebrandt L., Howell A. L. (2002). Intravenous fentanyl increases natural killer cell cytotoxicity and circulating CD16(+) lymphocytes in humans. Anesth. Analg. 94, 94–99
    1. Yu S. K., Tait G., Karkouti K., Wijeysundera D., Mccluskey S., Beattie W. S. (2011). The safety of perioperative esmolol: a systematic review and meta-analysis of randomized controlled trials. Anesth. Analg. 112, 267–281
    1. Zagon I. S., Hytrek S. D., Mclaughlin P. J. (1996). Opioid growth factor tonically inhibits human colon cancer cell proliferation in tissue culture. Am. J. Physiol. 271, R511–R518
    1. Zagon I. S., Mclaughlin P. J. (2003). Opioids and the apoptotic pathway in human cancer cells. Neuropeptides 37, 79–88
    1. Zagon I. S., Roesener C. D., Verderame M. F., Ohlsson-Wilhelm B. M., Levin R. J., Mclaughlin P. J. (2000). Opioid growth factor regulates the cell cycle of human neoplasias. Int. J. Oncol. 17, 1053–1061

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner